SHARE:  
  • This fall, 2023, OGS has started to run an in-person Cayuse training session for the DAs on a monthly basis at the library training room. This small group hands-on training session is by invitation only. Please send your email request to OGS@einsteinmed.edu if you would like to participate.




  • ALL proposals (both federal and non-federal, including limited submissions and private foundations) must be reviewed and approved by OGS first in Cayuse before final submission to the funding agencies.


  • We strongly recommend submitting the applications to funding agencies at least 24 - 48 hours before the sponsor deadline date and time.
  • For eRA Commons user ID setup and verification, contact Cynthia Cardillo.


  • For JIT, FIS, NCE, Carryover and any help with ASSIST, contact Bethany Oates.


  • Melanie Bourghol coordinates proposal review in Cayuse SP and 424.


  • Select Dr. Indranil Basu as SO, BO or AOR as you find on the drop-down menu of the grant application portals. For DOD proposals, select Dr. Basu's name on both #5 and #19 in Cayuse SF424RR.


  • DMS Plan review requests may be made to Dr. Indranil Basu at least 3 days before the grant deadline. Make sure to address all 6 elements without any URLs or hyperlinks. The NIH and DOD DMS plan templates are available on request.

NIH Webinar


October 17, 2023: 1-2 PM EST

All About NIH Subaward Agreements - Join the NIH Office of Policy for Extramural Research Administration (OPERA) experts as they guide you through each element of a subaward agreement, providing thorough instructions and underlining key policies. Register here for this free event.

NCURA Webinar

October 30, 2023: 2-3.30 PM EST

NIH Data Management and Sharing Policy - Budgeting and Application - Tips and Tricks (or Treat?) - Cynthia Cardillo will share the login details with the DAs a couple of days before the webinar.

Important links, forms and documents

Please find here the RPPR routing process in eRA Commons.

Please click here for the slide deck of the OGS DA roundtable meeting on 9/5/23.

Institutional Giving - Montefiore Einstein


Institutional Giving is part of the Office of Development and Alumni Affairs.

The list of Non-Governmental Funding Opportunities from the Office of Development’s Institutional Giving Team can be found here.

NIH Updates

Weekly NIH Funding Opportunities and Notices - 2023



Please click the dates below to find out the NIH funding opportunities September 15, September 22, September 29, October 06 and October 13.

NOT-OD-23-161: NIH Application Instruction Updates Data Management and Sharing (DMS) Costs

Effective for applications submitted for due dates on or after October 5, 2023, NIH will require applicants to specify estimated "DMS cost" details within the “Budget Justification” attachment of the R&R Budget Form or “Additional Narrative Justification” attachment of the PHS398 Modular Budget Form, pursuant to the instructions.

While the single cost line item is no longer required, "DMS costs" must be requested in the appropriate cost category, e.g. personnel, equipment, supplies, and other expenses, following the instructions for the R&R Budget Form or PHS 398 Modular Budget Form, as applicable. The link to the NIH announcement dated July 31, 2023 can be found here.

Read More

National Institutes of Health | Division of Loan Repayment

The NIH Extramural Loan Repayment Program (LRP) application cycle is open from September 1 to November 16 this year. Participants in the NIH LRPs can receive up to $100,000 of qualified educational debt repayment with a two-year award. Please contact lrp@nih.gov for further details

Read More

Funding Opportunities - Department of Defense, Congressionally Directed Medical Research Programs: Transforming Health Care through Innovative and Impactful Research

Please click read more to find the open funding opportunities.

Read More

NIH Common Data Elements (CDEs) and their Impact in Mental Health Research


If your grant is subject to NOT-MH-20-067 and/or NOT-MH-23-105, the NIMH Data Archive will prepopulate your Data Expected List with the appropriate NIH CDEs, along with the Research Subject & Pedigree data structure, in the Mandatory Data Structures section.

To further understand the value and purpose of CDEs, please explore the following publications: 

If you want to alter the initial set of Data Structures added to your Data Expected List, please submit a ticket via email to the NDA Help Desk with a justification for the change.

Any requests not to collect data for any of the Mandatory CDEs should be sent to your Program Officer (PO) and/or to Gregory K. Farber, Ph.D. at farberg@mail.nih.gov for approval.


There is a new streamlined process for populating your Data Expected List. As part of these new guidelines, you can request data structure modifications directly from your NDA Collection. Once the data structure request is added to your Data Expected List, the NDA Data Curation team will be notified automatically - you don't need to email the NDA Help Desk.

Complete instructions on setting up your Data Expected List are available below. Data structure modifications and new data structure requests must follow the new procedures for the NDA Data Curation team to process your request.

Beginning October 23, 2023, NSF will require all Biosketch and Current and Pending documents to be created in SciENcv. Please refer to NSF’s FAQs on how to sign-in to SciENcv and prepare key personnel documents. Find some reference materials (links below) regarding the SciENcv information, helpful in populating NSF or NIH biosketches and/or NSF current and pending support as well: -

Click the video and slide deck links.

Einstein 2030 Seed Fund


One new initiative funded by the recent $100 million anonymous gift to Einstein is the establishment of the Einstein 2030 Seed Fund. This fund will provide about $700,000/year to support studies by investigators that will enable them to generate the critical data and proof of concept studies that will serve as a pathway toward NIH funding.  

  

While preference will be given to funding early or mid-career faculty, these seed funds are available to all Einstein principal investigators engaged in basic research to be utilized to support start-up efforts and new lines of research that show significant promise. The individual awards will range from $50,000-$150,000, with funding at the $150,000 level reserved for outstanding projects with well-justified budgets. Investigators can include funding for their effort on the project and these awards may be renewable based on strong evidence of significant progress. 

  

The primary purpose of the Einstein 2030 Seed Fund is to support basic science research with potential translational applications and to bring discoveries to their next phase of evidence-based findings that will generate funding from NIH or other external sources. Review criteria used during the review process will be based on the reviewers’ assessment of the likelihood for the project to have a high impact and powerful influence on the research field(s) involved and strong potential for the proposed studies to generate results that will support the submission of a research project that will ultimately be funded by the NIH. 

  

Eligibility: Applicants must be tenure-track faculty members holding the rank of Assistant Professor or higher. 

 

For review of your application by Einstein’s Awards Committee, please send a single PDF file containing the following as an email attachment to indranil.basu@einsteinmed.edu by November 15, 2023:


1.Front page: (i) Title of the project; (ii) names of principal investigator and co-investigators, and their departmental affiliations; and (iii) abstract (up to 200 words). No institutional signatures are required. 


2.Project description: Up to 3 pages (including specific aims, significance, innovation, and research design) plus one additional page for references. The project description should be single-spaced, 11-point font or larger, and margins should be at least 0.5 inches. Figure legends can use a smaller font. 


3.Statement regarding future funding: On a separate page, applicants must include a short paragraph outlining how this seed funding will lead to a future NIH grant application. 


4.Budget: Standard NIH format, with up to one page of budget justification. 


5.Biographical Sketch: Standard NIH format, including Contribution to Science section. 


6.Other Support: Information about applicant’s active and pending grant support, with amounts requested or approved, annual amounts, and duration of award.

Non-Federal Funding Opportunities












Limited Submission







2024 Blavatnik National Awards for Young Scientists (for faculty members only) 

Our institute has been invited to submit 3 nominations (one in each disciplinary category of Life Sciences, Physical Sciences & Engineering, and Chemical Sciences). Please find full details of candidate eligibility and evaluation in the 2024 Blavatnik National Awards Nomination Guidelines. One winner in each category will be awarded $250,000 unrestricted funds.  

Eligibility of the Applicants: 

 

Nominees must - 

  • Have been born in or after 1982*. 
  • *Age-limit exceptions will be considered by the Blavatnik Family Foundation in exceptional circumstances upon a detailed written submission from the nominating institution received by the Academy at blavatnikregionalawards@nyas.org no later than Wednesday, November 08, 2023.  
  • Hold a doctorate degree (PhD, DPhil, MD, DDS, DVM, etc.). 
  • Currently hold a tenured or tenure-track academic faculty position, or equivalent, conducting research in one of the disciplinary categories in Chemical Sciences, Life Sciences, or Physical Sciences & Engineering. 
  • Please learn about the updated 2024 Blavatnik Regional Awards Nomination Guidelines  for details on candidate eligibility and selection criteria. 


In order to implement the application process for this competition, eligible faculty members are invited to submit preliminary applications, upon the recommendation of the appropriate department chair(s), for review by the Awards Committee. From among these applications, the Committee will make recommendations and will select one candidate for each of the three disciplinary categories: Life Sciences, Physical Sciences & Engineering, and Chemical Sciences. The deadline for submission of preliminary applications for internal review by the Awards Committee is 5 pm, Tuesday, October 24th, 2023.  

 

For internal review of your application by the Awards Committee, please send a single (one) PDF file containing the following as an email attachment to indranil.basu@einsteinmed.edu:  

1. Candidate Profile Form; download from this link.  

2. A statement outlining the applicant’s career potential and the Department’s plans for his/her future to be obtained from the Department Chairperson, limited to no more than two single-spaced pages.  

3. A written proposal containing the title, a specific disciplinary category of submission (whether Life Sciences, or Physical Sciences & Engineering, or Chemical Sciences), and a description of the proposed research project to be carried out during the grant period, up to 3 pages (including specific aims, significance, innovation, and research design) plus one additional page for references. The project description should be single-spaced, 11-point font or larger, and margins should be at least 0.5 inches. Figure legends can use a smaller font.

4. A complete curriculum vitae and bibliography. Include invited presentations but not abstracts. Please click here to find the recommended format for curriculum vitae.  

5. Information about present and pending grant support with amounts requested or approved, annual amounts, and duration of award. 


The applicants must hold a tenured or tenure-track academic faculty position, and those with a faculty rank (e.g., Instructor, Staff Scientist, Research Assistant Professor) are NOT eligible.

Our institution has been invited to submit two applications for the 2024 Gordon and Betty Moore Inventor Fellows Program. The Moore Inventor Fellowship supports early-career scientist-inventors who create new tools and technologies with a high potential to accelerate progress in the foundation’s three main areas of interest: Scientific research, Environmental conservation, and Patient care. The Moore Foundation recognizes a broad array of academic programs. Examples of such programs include, but are not limited to, environmental science and conservation, remote sensing, artificial intelligence, big data, climatology, emerging infectious diseases, oceanography, biology, engineering, physics, chemistry, materials science, neuroscience, and public health. They focus on supporting scientist-inventors at a critical prototyping stage of their innovations to support their work in ways that might be missed in the current research and development system. Each fellow will receive $200,000 per year from the foundation for three years. In addition, the foundation will provide the host institution with $25,000 each year to cover costs associated with administering the grant, resulting in a total three-year award of $675,000. Also, as required by the Foundation guidelines, the College will commit to ensuring that the nominee has at least 25 percent of their time to devote to their invention and $50,000 per year in direct support of the inventor’s work. This can be “in kind” as released time or access to special facilities for which there is normally a charge.  

  

Eligibility of the applicants and projects:  

  • Candidates must be a tenure-track faculty member with no more than 10 years past receiving the terminal advanced degree in their field (M.S., Ph.D. or M.D. received on or after 2014).  
  • The proposed project should be broadly within the program areas of the Foundation’s interest (science, environmental conservation, and patient care).  
  • For patient care, inventions should resonate with the Foundation’s focus on improving the experience and outcomes of patients with solutions that improve clinical diagnosis.  
  • The Foundation aims to support inventions at an early stage that could lead to proof-of-concept of an invention or advance an existing prototype that tackles an important problem. They seek innovations that promise to make a long-lasting and meaningful impact by addressing underlying problems in their field, but a clear path toward commercialization is not a requirement.  
  • The Foundation does not support fundamental research projects or projects already at a stage where significant venture capital is available.  


Please visit this webpage to find some of the recently funded projects by the Moore Foundation. In order to implement the application process for this competition, eligible faculty members are invited to submit preliminary applications, upon the recommendation of the appropriate department chair(s), for review by the Awards Committee. From among these applications, the Committee will make recommendations and will select two candidates for submitting applications for the 2024 Moore Inventor Fellows Program.  

  

The deadline for submission of preliminary applications for internal review by the Awards Committee is 5 pm, Monday October 30th, 2023.  

  

For internal review of your application by the Awards Committee, please send a single (ONE) PDF file containing the following as an email attachment to indranil.basu@einsteinmed.edu:  

1.  Candidate Profile Form; download from this link.  

2.  A statement outlining the applicant’s career potential and the Department’s plans for his/her future to be obtained from the Department Chairperson, limited to no more than TWO single-spaced pages.   

3.  A complete curriculum vitae and bibliography. Include invited presentations but not abstracts. Please click here to find the recommended format for curriculum vitae.  

4.  Statement of invention (no more than two pages, including citations; single-spaced, Arial or Georgia 12-point font with one-inch margins): The first paragraph should describe clearly and without jargon the invention, the problem it seeks to address and its potential impact. The statement of invention should also include the following information:  


  • Description of invention 
  • Stage of invention  
  • Feasibility  
  • Current funding  
  • Importance to the Foundation’s focus areas (Science, Patient care, or Environmental conservation - please select one choice) 
  • Potential impact  
  • Risks (please describe any technical risks that might lower chances of success and what you will do to mitigate these risks. For example, “If A doesn't work, we'll do B.”)
  • Approach to measuring success and progress over the 3-year fellowship  


The Foundation’s nomination-submission deadline is November 14, 2023. The full application is due by December 13, 2023. Once our Awards Committee selects the nominees, the College will submit the selected nominations to the Foundation prior to November 14th. To know the details of the application requirements, process and evaluation criteria, please access the Application Guidelines and FAQ page. If you have any questions concerning this award or the application procedure, please contact indranil.basu@einsteinmed.edu.  












Limited Submission






2024 Gordon and Betty Moore Inventor Fellows Program










Limited Submission







2024 Blavatnik Regional Awards for Young Scientists (for postdocs only)

Our institute has been invited to submit 15 nominations for the 2024 Blavatnik Regional Awards for Young Scientists. We encourage all postdocs to take advantage of the full 15 possible nominations. There are no citizenship restrictions. Three winners will each receive $30,000 in unrestricted funds and six finalists will each receive $10,000 in unrestricted funds. 


Eligibility of the Applicants: 


Nominees must - 

Have been born in or after 1982* 

*Age-limit exceptions will be considered by the Blavatnik Family Foundation in exceptional circumstances upon a detailed written submission from the nominating institution received by the Academy at blavatnikregionalawards@nyas.org no later than Wednesday, November 08, 2023.  

  • Hold a doctorate degree (PhD, DPhil, MD, DDS, DVM, etc.). 
  • Currently conducting research in one of the disciplinary categories in Chemical Sciences, Life Sciences, or Physical Sciences & Engineering. 
  • Please learn about the updated 2024 Blavatnik Regional Awards Nomination Guidelines for details on candidate eligibility and selection criteria. 
  • In order to implement the application process for this competition, eligible postdocs are invited to submit applications for review by the Awards Committee. From among these applications, the Committee will make recommendations and will select 15 candidates for submitting the nominations. 
  • The deadline for submission of applications for internal review by the Awards Committee is 5 pm, Tuesday, October 31st, 2023.
  • Please find the nomination materials and instructions at this link: Nomination Materials and Instructions. Please follow the guidelines at the link to send your nomination packet to Indranil Basu (indranil.basu@einsteinmed.edu) as a SINGLE PDF with the title LASTNAME_Blavatnik-Regional on or before October 31st, 2023. 


  • The applicants must hold a postdoctoral position, and those with a faculty rank (e.g., Instructor, Staff Scientist, Research Assistant Professor) are NOT eligible.


The Office of Development and Alumni Relations along with the Office of Grant Support and the Einstein Awards Committee is excited to announce the W.M. Keck Foundation’s Research funding opportunity. Grants of $1 million will be awarded for a maximum period of three years. Senior, mid-career or early-stage faculty (tenure-track assistant professors or above) can apply.  

  

The mandate of the W.M. Keck Foundation’s Research Program is to support pioneering discoveries in Medical Research and Science & Engineering. The Foundation funds high-risk and high-impact work of leading researchers to lay the groundwork for new paradigms, technologies, and discoveries that will save lives, provide innovative solutions, and add to our understanding of the world. They are seeking paradigm-shifting proposals dealing with basic science, and ideas that have “potential to break open new territory in their field.” Translational applications down the line are seen as a plus, but this is not their focus.

  

The W.M. Keck Foundation funds fundamental science projects in two specific areas: 1) Medical Research and 2) Science and Engineering (S&E). 

  

Foundation will fund scientific research which is: 

  • A breakthrough / scientific leap forward (in this project) 
  • Project can be hypothesis-driven, but it does not have to be 
  • High impact / possibly high risk 
  • The project team has the necessary expertise 
  • Project-driven instrumentation can be included 
  • Have potential to develop breakthrough technologies, instrumentation, or methodologies
  • Demonstrate a high level of risk due to unconventional approaches or challenge the prevailing paradigm
  • Have potential for transformative impact such as the founding of a new field of research, enabling of new observations, or altering perception of a previously intractable problem
  • Project falls outside the mission of public funding agencies (e.g., NIH, NSF, DoD, etc.).  
  • Applicants need to demonstrate why private philanthropy generally, and the Keck Foundation in particular, is essential to the project’s success. The foundation wants applicants to insert direct quotes received from public funding agencies' feedback as to why their project did not get funded (e.g., “high-quality but too risky”).  

The foundation will not fund the following: 

  • Drug development and delivery/biomarker identification 
  • Treatment trials or research for the sole purpose of drug development
  • Medical devices and translational research
  • Clinical research / therapies 
  • Extension of current work/next logical step — even if significant 
  • Projects that are too narrow/too specific, including disease-specific
  • User facilities 
  • Application, efficiency/optimization, or cost cannot be the main drivers 
  • No supplements or renewals   

 

The deadline for submission of concept papers for internal review by the Einstein Awards Committee is Tuesday November 14th, 2023. Please email your single-paged concept paper as a PDF following the outline given below to: indranil.basu@einsteinmed.edu by November 14.  

  

Single-paged concept papers must be in 12 point font with 1 inch margins and include: 

  • Organization Name 
  • Project Title 
  • Full name of Principal Investigator 
  • An overview of the proposed project emphasizing any unique aspects and pilot studies (indicate area of emphasis for project – Medical Research or Science & Engineering Research) 
  • A description of the methodologies and key personnel 
  • A brief justification of the need for Keck Foundation support Applicants need to demonstrate why private philanthropy generally, and the Keck Foundation in particular, is essential to the project’s success. The foundation wants applicants to insert direct quotes received from public funding agencies feedback as to why their project did not get funded (e.g., “high-quality but too risky”). 
  • An estimated budget broken down, if possible, by major areas, e.g. personnel, equipment, consumable supplies, etc. 
  • With any remaining space within the 1 page limit, authors may add other details 
  • If a reference is necessary, abbreviate it as (Science, 323, 45, ‘11). DO NOT USE (Jones et al., 2011). Please avoid any illustrations.   

 

Please find details of Keck Foundation Grant Program Eligibility and Priorities. Please visit the Foundation's Grant Abstracts Webpage to view the types of research projects and award amounts recently funded by the Keck Foundation. From among these applications, the Einstein awards committee will make recommendations and nominate up to four candidates for each of the two categories (Medical Research and S&E), for a total of up to eight concept paper candidates. Einstein’s institutional liaison officer will then submit the nominated concept papers to the Foundation for a preliminary review before January 1st, 2024. Following this review, selected applicants will be invited to submit a Phase I application by May 1, 2024. Faculty members who have previously submitted a concept paper to the Einstein awards committee but were not selected to move ahead based on feedback received from the foundation, are most welcome to submit a concept paper. If you have any questions, please contact amcinerney@montefiore.org (Institutional Liaison Officer).









Limited Submission







W.M.Keck Foundation Scientific Research Funding Opportunity

Career Awards for Medical Scientists - Burroughs Wellcome Fund

Deadline: October 17, 2023

Amount: $700k/5 years

About: This award is for physician-scientists who are committed to an academic career, to bridge advanced postdoctoral/fellowship training and the early years of faculty service. Proposals must be in basic biomedical, disease-oriented, or translational research. Proposals in health services research or involving large-scale clinical trials are not eligible. BWF anticipates making up to 12 awards including up to two awards to clinically trained psychiatrists who focus their research at the interface between psychiatry and neuroscience. Proposals that incorporate artificial intelligence and machine learning or climate change and human health are of particular interest.

Eligibility: Candidates must hold an MD, DO, DVM, VMD, or DDS; have completed clinical training (residency or fellowship) and be board eligible by award start date; may hold a junior faculty appointment (Lecturer, Instructor, Assistant Professor-non-tenure track, etc.); must be citizen or non-citizen permanent and temporary US resident legally qualified to work in the US. Additional requirements in the link below.

Links:  BWF CAMS 2024 RFP and FAQs

Contact: Audrey McInerney (amcinerney@montefiore.org) for more information and/or assistance.

Read More

Apply to the Academic Clinical Trials Program

The Leukemia & Lymphoma Society (LLS) is pleased to announce the opening of the Academic Clinical Trials Program for 2023-2024.

The LLS ACT initiative is a clinical trial award program designed to develop cutting edge treatments that will have a meaningful impact on blood cancer patients. These awards will fund clinical trials, up to $1M USD over a period of up to three years. The LOI is due on October 25, 2023, 3 PM (EST). The ACT program guidelines and instructions can be found here.

LLS is seeking truly novel advances. The LLS ACT initiative is designed to develop experimental agents to address unmet medical needs, expand the use of approved therapeutics, and improve the use of novel treatment regimens in clinical settings.

Projects addressing follicular lymphoma may be selected for co-funding. This funding will be provided in a collaborative partnership between LLS and the Follicular Lymphoma Foundation. Please see the Cure FL Appendix in the ACT guidelines and instructions, which can be located at the lls.org link below.

A detailed description of the LLS Academic Clinical Trials Program and application instructions are available on the LLS Research Portal or the LLS site. All applications are to be submitted online through the LLS Research Portal. For additional questions regarding LLS research grant programs, eligibility, and application processes, please contact researchprograms@lls.org.

Read More

National Glaucoma Research Request for Proposals

New grants are available for research that begins in 2024, with an application deadline of October 31, 2023. BrightFocus provides research funds for U.S. domestic as well as international researchers to cover a wide range of investigator-initiated topics to better understand, treat, and prevent glaucoma, a leading cause of blindness. Please note that applicants to the NGR standard award program are encouraged to apply for funding to create tools that would benefit all investigators in the field, including animal models of disease, or cell lines. 

Postdoctoral Fellowship (maximum award value $150,000, 2 years)

Standard Award (maximum award value $200,000, up to 2 years)

Visit BrightFocus/NGR-RFP for more information about the BrightFocus glaucoma grants, including how to apply

Read More

CRI Technology Impact Award – LOIs due November 15.

 

Provides seed funding to address the gap between technology development and clinical application of cancer immunotherapies. Academic faculty (assistant professor or higher rank) are invited to apply. Tech Impact Awards provide up to $200,000 over two years.

 

CRI Clinical Innovator – Protocol concepts due December 1.

 

Supports novel clinical studies that address areas of high unmet need in cancer and seek mechanistic insights into clinical response with the goal of predictive biomarker discovery. Up to $1M per trial.


CRI Clinic & Laboratory Integration Program (CLIP) - LOIs due December 1.

 

CLIP provides catalytic support for the translation of basic laboratory discoveries into novel therapies that can be tested in patients. CRI is pleased to announce an increase in the award amount for new CLIP grants. Awards now provide up to $300,000 over two years.


CRI Lloyd J. Old STAR Program – Applications due January 15.


Long-term funding for mid-career scientists pursuing high-risk, high-reward research at the forefront of discovery and innovation in cancer immunotherapy. CRI STARs are expected to be the future leaders in the field. STARs receive $1.25M over five years.


Click here to find all the CRI funding opportunities.

Alkermes Pathways Research Awards Program


The application period for the Alkermes Pathways Research Awards® programis now open. 

Pathways Research Awards are open tojunior investigators and will support research projects focused on schizophrenia and bipolar disorder

The annual Pathways program provides individualgrants up to $100,000 per project. For more information and full eligibility criteria, please click here.

Applications close on November 30, 2023 (by 11:59 PM Eastern Time). 

For more information on Pathways, please submit a query using the Pathway's Research Award Inquiry Form

Please note the new OGS email address: OGS@einsteinmed.edu